Meade designs bioinorganic coordination complexes and nanoparticle- and genetically-encoded contrast agents that act as activatable molecular MRI sensors, reporting on enzyme activity, gene expression, and neurochemistry in living tissue, alongside electronic biosensors and transcription-factor inhibitors for molecular imaging and diagnostics.